DOXGX has more cash in the bank: 118B vs. SLVAX (3.16B). SLVAX (1.17) and DOXGX (1.14) have matching dividends . DOXGX was incepted earlier than SLVAX: DOXGX (4 years) vs SLVAX (29 years). SLVAX (1.07) is less costly to investors than DOXGX (0.46). SLVAX is a more actively managed with annual turnover of: 28.00 vs. DOXGX (20.00). SLVAX has a lower initial minimum investment than DOXGX: SLVAX (2000) vs DOXGX (2500). SLVAX annual gain was more profitable for investors over the last year : 27.78 vs. DOXGX (14.64).

	DOXGX	SLVAX	DOXGX / SLVAX
Total Expense Ratio	0.41	0.85	48%
Annual Report Gross Expense Ratio	0.46	1.07	43%
Fund Existence	4 years	29 years	-
Gain YTD	8.891	16.576	54%
Front Load	N/A	6%	-
Min. Initial Investment	2500	2000	125%
Min. Initial Investment IRA	N/A	N/A	-
Net Assets	118B	3.16B	3,731%
Annual Yield % from dividends	1.14	1.17	98%
Returns for 1 year	14.64	27.78	53%
Returns for 3 years	117.62	52.60	224%
Returns for 5 years	N/A	60.00	-
Returns for 10 years	N/A	129.13	-

View a ticker or compare two or three

Ask AI

Compare

Interact to see
Advertisement

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
BCAX	27.10	0.83	+3.16%
Bicara Therapeutics Inc.
XCBEU	10.03	N/A	N/A
X3 Acquisition Corp Ltd
TTD	18.04	-0.24	-1.31%
Trade Desk (The)
STG	3.29	-0.11	-3.09%
Sunlands Technology Group
UPB	6.31	-0.26	-3.96%
Upstream Bio Inc